about
Ovariectomized OVA-sensitized mice display increased frequency of CD4(+)Foxp3(+) T regulatory cells in the peripheryLow level laser therapy reduces acute lung inflammation in a model of pulmonary and extrapulmonary LPS-induced ARDS.Home-based pulmonary rehabilitation improves clinical features and systemic inflammation in chronic obstructive pulmonary disease patients.Low Level Laser Therapy Reduces the Development of Lung Inflammation Induced by Formaldehyde ExposureAerobic Exercise Attenuated Bleomycin-Induced Lung Fibrosis in Th2-Dominant Mice.Short-term hyperprolactinemia decreases allergic inflammatory response of the lungs.Compensatory lung growth after bilobectomy in emphysematous rats.Formaldehyde inhalation reduces respiratory mechanics in a rat model with allergic lung inflammation by altering the nitric oxide/cyclooxygenase-derived products relationship.Melatonin modulates allergic lung inflammation.3,4-methylenedioxymethamphetamine (ecstasy) decreases inflammation and airway reactivity in a murine model of asthma.Exercise Inhibits the Effects of Smoke-Induced COPD Involving Modulation of STAT3.Light-Emitting Diode treatment ameliorates allergic lung inflammation in experimental model of asthma induced by ovalbumin.Effects of MK-801 and amphetamine treatments on allergic lung inflammatory response in mice.Low-Level Laser Therapy Reduces Lung Inflammation in an Experimental Model of Chronic Obstructive Pulmonary Disease Involving P2X7 Receptor.Aerobic Exercise Protects from Pseudomonas aeruginosa-Induced Pneumonia in Elderly MiceShort-Term Hyperprolactinemia Reduces the Expression of Purinergic P2X7 Receptors during Allergic Inflammatory Response of the LungsSolvent and HEMA Increase Adhesive Toxicity and Cytokine Release from Dental Pulp CellsLong-term amphetamine treatment exacerbates inflammatory lung reaction while decreases airway hyper-responsiveness after allergic stimulus in rats
P50
Q31120325-D649210D-1591-4311-8AC2-227A72E7A3D7Q35162380-8B581287-6FA1-4C41-882A-DE1E9CA813B8Q35223218-B882337A-90BF-4AA7-B7CB-15381C0D079CQ35841632-CFD8A4EA-9944-4325-B244-31E2E036CCCFQ36146139-24E5051A-941A-490A-8FC0-A2B225F530E9Q40419736-F967F48E-88C0-46B5-A487-7E3A65E336A3Q41154082-D73B8DB2-E2F7-4D1F-BBEE-4BA59C7D1FFCQ42710214-9799C14C-EE48-4039-B233-67AED9D99F2DQ43795935-D17157E0-D5CC-494B-9F64-2809DB4A69D3Q46636405-8051B7AA-E759-4EE6-9411-C3B25E817475Q47658841-F446E61E-47B0-41DE-AA87-B57E2E4EC7AFQ47917137-1E397733-131A-4B04-8A69-DE8DEE49A2FEQ51019547-6E330435-1F5D-43DD-8858-DD332F229DD9Q52568281-DCBBFF90-D683-41C8-A9D2-FCFAA8EBB855Q88906754-B3EF0493-43FF-4FD1-B723-3FD0A91D174CQ89011462-BFB2BCB4-EDCE-4C12-B0AD-BF2DE5EDBF30Q92960270-2F5CD4F6-86F9-4F5A-A09B-6E250548228DQ95423860-D89E268D-B7EE-4FFA-BE32-CAB2BB70A057
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-6089-5107
@en
name
Ana Paula Ligeiro de Oliveira
@ast
Ana Paula Ligeiro de Oliveira
@en
Ana Paula Ligeiro de Oliveira
@es
Ana Paula Ligeiro de Oliveira
@nl
type
label
Ana Paula Ligeiro de Oliveira
@ast
Ana Paula Ligeiro de Oliveira
@en
Ana Paula Ligeiro de Oliveira
@es
Ana Paula Ligeiro de Oliveira
@nl
prefLabel
Ana Paula Ligeiro de Oliveira
@ast
Ana Paula Ligeiro de Oliveira
@en
Ana Paula Ligeiro de Oliveira
@es
Ana Paula Ligeiro de Oliveira
@nl
P106
P108
P21
P31
P496
0000-0001-6089-5107